Breast MRI in Patients With Active Implanted Metallic Devices: How We Do It

View at publisher
Authors: Jeremiah Sanders, Anshuman Panda, Laura Harper, Bhavika Patel, Richard E. Sharpe
Cited by: 2
References: 15

Abstract

Given increases in both breast MRI utilization and the prevalence of active implanted metallic devices (AIMDs), radiology practices are expected to encounter a growing number of referrals for breast MRI among patients with AIMDs. Under MRI, AIMDs can experience forces and torques, vibrations, heating, and electrical interference or malfunction. AIMDs also distort the magnetic field, causing signal voids, signal pile-up, geometric distortion, and fat suppression failure. However, limited guidance exists regarding safely performing breast MRI in this patient population. This Perspective presents approaches for safely performing breast MRI in patients with AIMDs while maintaining diagnostic integrity. Key components include multistep screening for early identification of AIMDs, adherence to vendor MRI-conditional guidelines, and protocol modification techniques to meet these guidelines while balancing image quality, scanning time, and artifact mitigation. Illustrative clinical cases show breast MRI examinations performed safely for patients with various AIMDs, including a cardiac pacemaker, cardiac loop recorder, sacral nerve stimulator, responsive neurostimulator, hypoglossal nerve stimulator, spinal cord stimulator, and deep brain stimulator. Situations in which MRI is inadvisable and alternative modalities may be preferred are also considered. New CPT codes for MRI safety are also highlighted. Implementing the described workflows can expand safe access to breast MRI for patients with AIMDs.

Fields of Study & Subjects

Advanced MRI Techniques and Applications Cardiac pacing and defibrillation studies Cardiac Imaging and Diagnostics

Publication details

Journal / source
American Journal of Roentgenology
Publisher
American Roentgen Ray Society
Volume
227
Issue
1
Pages
e2634661–e2634661
Publication date
25 March 2026
Language
EN